Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels

Journal of Cell Biology

Volumn 163, Issue 4, 2003, Pages 871-878

  Christian, Sven ^a   Pilch, Jan ^a   Akerman, Maria E ^a,b   Porkka, Kimmo ^a,c   Laakkonen, Pirjo ^a,d   Ruoslahti, Erkki ^a  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Angiogenesis; Bone marrow; Cell penetrating peptides; Nuclear proteins

Indexed keywords

AUTOANTIBODY; BIOTIN; FLUORESCEIN; MATRIGEL; NUCLEOLIN; NUCLEOLIN ANTIBODY; PEPTIDE; PROTEIN F3; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BREAST CARCINOMA; CANCER CELL CULTURE; CELL GROWTH; DRUG DELIVERY SYSTEM; ENDOTHELIUM CELL; INTERNALIZATION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN TRANSPORT; TUMOR VASCULARIZATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANTIBODIES; ANTIGENS, SURFACE; BLOOD VESSELS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MEMBRANE; CULTURE MEDIA, SERUM-FREE; ENDOCYTOSIS; ENDOTHELIUM, VASCULAR; EPITOPES; HEPARITIN SULFATE; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHOPROTEINS; RNA-BINDING PROTEINS; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA;

EID: 0344304541     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.200304132     Document Type: Article

References (41)

1. Akerman, M.E., W.C. Chan, P. Laakkonen, S.N. Bhatia, and E. Ruoslahti. 2002. Nanocrystal targeting in vivo. Proc. Natl. Acad. Sci. USA. 99:12617-12621.
2. Arap, W., R. Pasqualini, and E. Ruoslahti. 1998. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science. 279:377-380.
3. Bergers, G., R. Brekken, G. McMahon, T.H. Vu, T. Itoh, K. Tamaki, K. Tanzawa, P. Thorpe, S. Itohara, Z. Werb, and D. Hanahan. 2000. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2:737-744.
4. Bonnet, H., O. Filhol, I. Truchet, P. Brethenou, C. Cochet, F. Amalric, and G. Bouche. 1996. Fibroblast growth factor-2 binds to the regulatory beta subunit of CK2 and directly stimulates CK2 activity toward nucleolin. J. Biol. Chem. 271:24781-24787.
5. Borer, R.A., C.F. Lehner, H.M. Eppenberger, and E.A. Nigg. 1989. Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell. 56:379-390.
6. Brooks, P.C., S. Silletti, T.L. von Schalscha, M. Friedlander, and D.A. Cheresh. 1998. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell. 92:391-400.
7. Christian, S., H. Ahorn, A. Koehler, F. Eisenhaber, H.P. Rodi, P. Garin-Chesa, J.E. Park, W.J. Rettig, and M.C. Lenter. 2001a. Molecular cloning and characterization of endosialin, a C-type lectin-like cell surface receptor of tumor endothelium. J. Biol. Chem. 276:7408-7414.
8. Christian, S., H. Ahorn, M. Novatchkova, P. Garin-Chesa, J.E. Park, G. Weber, F. Eisenhaber, W.J. Rettig, and M.C. Lenter. 2001b. Molecular cloning and characterization of EndoGlyx-1, an EMILIN-like multisubunit glycoprotein of vascular endothelium. J. Biol. Chem. 276:48588-48595.
9. Deng, J.S., B. Ballou, and J.K. Hofmeister. 1996. Internalization of anti-nucleolin antibody into viable HEp-2 cells. Mol. Biol. Rep. 23:191-195.
10. El-Sheikh, A., C. Liu, H. Huang, and T.S. Edgington. 2002. A novel vascular endothelial growth factor heparin-binding domain substructure binds to glycosaminoglycans in vivo and localizes to tumor microvascular endothelium. Cancer Res. 62:7118-7123.
11. Eliceiri, B.P., and D.A. Cheresh. 1999. The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J. Clin. Invest. 103:1227-1230.
12. Esko, J.D., T.E. Stewart, and W.H. Taylor. 1985. Animal cell mutants defective in glycosaminoglycan biosynthesis. Proc. Natl. Acad. Sci. USA. 82:3197-3201.
13. Fawell, S., J. Seery, Y. Daikh, C. Moore, L.L. Chen, B. Pepinsky, and J. Barsoum. 1994. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acac. Sci. USA. 91:664-668.
14. Ferrara, N., and K. Alitalo. 1999. Clinical applications of angiogenic growth factors and their inhibitors. Nat. Med. 5:1359-1364.
15. Fulgham, D.L., S.R. Widhalm, S. Martin, and J.D. Coffin. 1999. FGF-2 dependent angiogenesis is a latent phenotype in basic fibroblast growth factor transgenic mice. Endothelium. 6:185-195.
16. Ginisty, H., H. Sicard, B. Roger, and P. Bouvet. 1999. Structure and functions of nucleolin. J. Cell Sci. 112:761-772.
17. Hanahan, D., and J. Folkman. 1996. Patterns and emerging mechanisms of the angiogenic switch during tumotigenesis. Cell. 86:353-364.
18. Harms, G., R. Kraft, G. Grelle, B. Volz, J. Dernedde, and R. Tauber. 2001. Identification of nucleolin as a new L-selectin ligand. Biochem. J. 1360:531-538.
19. Hood, J.D., M. Bednarski, R. Frausto, S. Guccione, R.A. Reisfeld, R. Xiang, and D.A. Cheresh. 2002. Tumor regression by targeted gene delivery to the neovasculature. Science. 296:2404-2407.
20. Hovanessian, A.G., F. Puvion-Dutilleul, S. Nisole, J. Svab, E. Perret, J.S. Deng, and B. Krust. 2000. The cell-surface-expressed nucleolin is associated with the actin cytoskeleton. Exp. Cell Res. 261:312-328.
21. Hynes, R.O. 2002. A reevaluation of integrins as regulators of angiogenesis. Nat. Med. 8:918-921.
22. Joyce, J.A., P. Laakkonen, M. Bernasconi, G. Bergers, E. Ruoslahti, and D. Hanahan. 2003. Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis. Cancer Cell. In press.
23. Laakkonen, P., K. Porkka, J.A. Hoffman, and E. Ruoslahti. 2002. A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nat. Med. 8:751-755.
24. Langel, Ü. 2002. Cell-Penetrating Peptides: Processes and Applications. CRC Press, Boca Raton, FL. 406 pp.
25. Larrucea, S., C. Gonzalez-Rubio, R. Cambroneto, B. Ballou, P. Bonay, E. Lopez-Granados, P. Bouvet, G. Fontan, M. Fresno, and M. Lopez-Trascasa. 1998. Cellular adhesion mediated by factor J, a complement inhibitor. Evidence for nucleolin involvement. J. Biol. Chem. 273:31718-31725.
26. Ngo, C.V., M. Gee, N. Akhtar, D. Yu, O. Volpert, R. Auerbach, and A. Thomas-Tikhonenko. 2000. An in vivo function for the transforming Myc protein: elicitation of the angiogenic phenotype. Cell Growth Differ. 11:201-210.
27. Nilsson, F., H. Kosmehl, L. Zardi, and D. Neri. 2001. Targeted delivery of tissue factor to the ED-B domain of fibronectin, a marker of angiogenesis, mediates the infarction of solid tumors in mice. Cancer Res. 61:711-716.
28. Pasqualini, R., E, Koivunen, R. Kain, J. Lahdenranta, M. Sakamoto, A, Stryhn, R.A. Ashmun, L.H. Shapiro, W. Arap, and E. Ruoslahti. 2000. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res. 60:722-727.
29. Porkka, K., P. Laakkonen, J.A. Hoffman, M. Bernasconi, and E. Ruoslahti. 2002. A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo. Proc. Natl. Acad. Sci. USA. 99:7444-7449.
30. Roghani, M., and D. Moscatelli. 1992. Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms. J. Biol. Chem. 267:22156-22162.
31. Ruoslahti, E. 2002. Specialization of tumour vasculature. Nat. Rev. Cancer. 2:83-90.
32. Said, E.A., B. Krust, S. Nisole, J. Svab, J.P. Briand, and A.G. Hovanessian. 2002. The anti-HIV cytokine midkine binds the cell surface-expressed nucleolin as a low affinity receptor. J. Biol Chem. 277:37492-37502.
33. Schmidt-Zachmann, M.S., and E.A. Nigg. 1993. Protein localization to the nucleolus: a search for targeting domains in nucleolin. J. Cell Sci. 105:799-806.
34. Schwab, M.S., and C. Dreyer. 1997. Protein phosphorylation sites regulate the function of the bipartite NLS of nucleolin. Eur. J. Cell Biol. 73:287-297.
35. Shibata, Y., T. Muramatsu, M. Hirai, T. Inui, T. Kimura, H. Saito, L.M. McCormick, G. Bu, and K. Kadomatsu. 2002. Nuclear targeting by the growth factor midkine. Mol. Cell. Biol. 22:6788-6796.
36. Sinclair, J.F., and A.D. O'Brien. 2002. Cell surface-localized nucleolin is a eukaryotic receptor for the adhesin intimin-gamma of enterohemorrhagic Escherichia coli O 157:H7. J. Biol. Chem. 277:2876-2885.
37. Srivastava, M., and H.B. Pollard. 1999. Molecular dissection of nucleolin's role in growth and cell proliferation: new insights. FASEB J. 13:1911-1922.
38. St Croix, B., C. Rago, V. Velculescu, G. Traverso, K.E. Romans, E. Montgomery, A. Lal, G.J. Riggins, C. Lengauer, B. Vogelstein, and K.W. Kinzler. 2000. Genes expressed in human tumor endothelium. Science. 289:1197-1202.
39. Suzuki, T., S. Futaki, M. Niwa, S. Tanaka, K. Ueda, and Y. Sugiura. 2002. Possible existence of common internalization mechanisms among arginine-rich peptides. J. Biol. Chem. 277:2437-2443.
40. Tsutsui, J., K. Kadomatsu, S. Matsubara, A. Nakagawata, M. Hamanoue, S. Takao, H. Shimazu, Y. Ohi, and T. Mutamatsu. 1993. A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas. Cancer Res. 53:1281-1285.
41. Yu, D., M.Z. Schwartz, and R. Petryshyn. 1998. Effect of laminin on the nuclear localization of nucleolin in rat intestinal epithelial IEC-6 cells. Biochem. Biophys. Res. Commun. 247:186-192.